Cite
Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors
MLA
Gabriela Silva, et al. “Novel ScFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors.” Biomolecules, vol. 13, no. 3, Mar. 2023, p. 459. EBSCOhost, https://doi.org/10.3390/biom13030459.
APA
Gabriela Silva, Ana F. Rodrigues, Susana Ferreira, Carolina Matos, Rute P. Eleutério, Gonçalo Marques, Khrystyna Kucheryava, Ana R. Lemos, Pedro M. F. Sousa, Rute Castro, Ana Barbas, Daniel Simão, & Paula M. Alves. (2023). Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors. Biomolecules, 13(3), 459. https://doi.org/10.3390/biom13030459
Chicago
Gabriela Silva, Ana F. Rodrigues, Susana Ferreira, Carolina Matos, Rute P. Eleutério, Gonçalo Marques, Khrystyna Kucheryava, et al. 2023. “Novel ScFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors.” Biomolecules 13 (3): 459. doi:10.3390/biom13030459.